Results 261 to 270 of about 4,075,451 (292)
Some of the next articles are maybe not open access.
Chapter 4. Anti-Anxiety Agents, Anticonvulsants, and Sedative-Hypnotics
1981Publisher Summary Rapid advances have been made in understanding the neurochemical mechanisms of benzodiazepines (BZs) and similar compounds responsible for their therapeutic actions. The “GABA hypothesis” relating to the actions of BZs in the brain continues to gain support.
Richard C. Effland, Manfred F. Försch
openaire +1 more source
Chapter 1. Antipsychotic and Anti-anxiety Agents
1966Publisher Summary This chapter discusses various antipsychotic and anti-anxiety agents. Most of the compounds discussed in the chapter are tested by two general methods: (1) the study of animal behavior following drug treatment in experimental models designed to mimic a clinical situation (conflict, avoidance, etc.) and (2) the measurement of ...
openaire +1 more source
Chapter 2. Anti-Anxiety Agents, Anticonvulsants and Sedative-Hypnotics
1977Publisher Summary This chapter describes the metabolic studies of Lorazepam in man and animals, Pinazepams in man, Diazepam in human kidney cortex microsomes and bile, and Nitrazepam in rabbit urine. N-desmethyldiazepam is a new human metabolite of chlorodiazepoxid, e.g Diazepam and its main active metabolite desmethyldiazepam, pass into the breast ...
W HOULIHAN, G BENNETT
openaire +1 more source
Chapter 1. Antipsychotic and Antianxiety Agents
1972Publisher Summary This chapter presents results of studies that analyze antipsychotic and antianxiety agents. The use of long-acting fluphenazine in the management of schizophrenia and its comparison with conventional therapy was reviewed. Studies of other 6-6-6 tricyclics included several new phenothiaaine derivatives. A diazabicyclononane analog of
Charles L. Zirkle, Carl Kaiser
openaire +1 more source
Chapter 2: Anti-Anxiety Agents, Anticonvulsants, and Sedative-Hypnotics
1976Publisher Summary This chapter includes report of some novel structures of different compounds and its derivatives and analogs that continue to dominate the pharmacologically related areas of anti-anxiety, anticonvulsant, and sedative-hypnotic therapy.
openaire +1 more source
Chapter 2. Anti-Anxiety Agents, Anticonvulsants & Sedative-Hypnotics
1983Publisher Summary Studies on pharmacotherapy for anxiety continue to evolve along the dual paths of agents and actions. While benzodiazepines (BZs) continue to be the agents of choice for anxiolysis, new series of non-BZ compounds are emerging that may offer alternatives in the management of anxiety disorders.
Joseph P. Yevich +2 more
openaire +1 more source
Chapter 2. Anti-Anxiety Agents, Anticonvulsants, and Sedative-Hypnotics
1982Publisher Summary This chapter discusses the biochemical mechanisms of action of anxiolytics, anticonvulsants and sedatives, and to a better understanding of the causes and nature of the disorders for which they are used. Strong evidence continues to support a functional link between benzodiazepines (BZ), gamma-aminobutyric acid (GABA), and chloride ...
openaire +1 more source
Anti-anxiety agents and synaptic transmission in the brain : electrophysiological studies
1980This item was digitized as part of a project to share McGill's intellectual legacy with the public. If you are the copyright holder or a relative of the copyright holder who is deceased, you may request withdrawal by emailing escholarship.library@mcgill.ca.
openaire +1 more source
Anti-anxiety Properties of Selected Medicinal Plants
Current Pharmaceutical Biotechnology, 2022Muhammad Akram +2 more
exaly